The ABCs of Cardiac Care: Detailing the Immense Impact of Acuity in Data, Better Patient Experience, and Computational Power

Ways Healthcare Technology Is Improving Patient Safety

Data has always been at the center of cardiac diagnostics—even in its earliest form. The ECG’s predecessor, the galvanometer, emerged in 1903, enabling the first accurate recording of the heart’s electric activity. Holter monitors followed in 1949, extending the data monitoring window to 24 hours. These advancements made it possible to provide anticipatory interventions before catastrophic events occurred. Together, they laid the foundation for the remote cardiac monitoring used by providers today.

The last decade, however, has represented more leaps in technological capabilities than the last century of cardiac monitoring innovation combined. A new suite of advancements is upon us, which are fundamentally transforming the efficiency and effectiveness of cardiac workflows, diagnostics, and interventions. These advancements build upon the legacy of 24-hour monitoring while improving data fidelity, reducing friction in the patient experience, and amplifying insight through the power of AI.

Let’s take a closer look at the ABCs of virtual cardiac telemetry—three key breakthroughs that are already shaping a new generation of cardiac care. 

‘A’ for Acuity in Data: Enabling Hospital-Grade Monitoring from Nearly Anywhere 

Even after the advent of continuous monitoring in the latter half of the 1900s, acuity remained a barrier to remote monitoring’s potential applications. And the bar for data acuity is even higher for specialized or subtle cardiac conditions that may only reveal themselves in the area outside of a major event. 

In the past, remote monitoring simply couldn’t replicate the data fidelity of the hospital environment. Early remote monitoring devices were less sophisticated, with limited capabilities to monitor multiple parameters simultaneously. These devices couldn’t match the comprehensive monitoring provided by hospital-based systems that had integrated sensors and monitoring equipment that provided a holistic view of a patient’s health. 

But advancements in virtual telemetry have overcome historical obstacles related to data acuity, enabling hospital-grade monitoring from nearly anywhere. Patients no longer need to be confined to hospital beds to receive precise diagnostic monitoring, enabling new possibilities for the entire cardiac ecosystem. 

High-acuity remote monitoring data not only enhances diagnostic capabilities, but also enables proactive interventions that prevent minor cardiac issues from escalating into life-threatening events and allow for shorter hospital stays by offering close monitoring post-discharge. It also supports more personalized cardiac interventions by uncovering individualized indicators in each patient’s heartbeat—the unique signature of their heart that includes powerful clues and cues for more effective treatment. 

‘B’ for Better Patient Experience: Lowering Barriers to Adoption and Adherence 

However, even with the highest-quality acuity in data, virtual telemetry is nothing without patient adherence. As the starting line for successful remote monitoring, patient adherence is arguably the most significant determinant of success. But patient adherence remains an ongoing challenge. Approximately 50% of patients with chronic diseases do not adhere to their prescribed medication regimens, resulting in poor health outcomes and increased healthcare costs.

Patients often considered the complex, wire-laden remote monitoring devices of yesterday a nuisance. But conversely, modern clinical wearables have adopted best practices in consumer technology to create an intuitive and frictionless experience for patients. With little effort or technical experience, patients can power on their devices and enable the delivery of timely and precise cardiac monitoring data. 

These convenient, lightweight wearables ensure continuous data delivery to the physician regardless of location. This enables patients to go about their lives freely while paying little attention to the lead sets. 

‘C’ for Computational Power: Transforming High-Volume Data into Tangible Insight with AI 

Advancements in virtual telemetry have dramatically increased the acuity of monitoring data, and streamlined patient experience has increased adoption. But with this uptick in acuity and adoption comes a radical increase in data volume. In normal circumstances, this would mean more clinical burden, with many hours of analysis required. But AI-enabled analysis can instantly make sense of an immense amount of data with exceptional granularity and detail.

AI-driven models analyze cardiac data with exceptional speed and accuracy, identifying patterns and anomalies that may go undetected by the human reviewer. This enables early detection of potential cardiac issues, allowing for more timely, targeted interventions. For instance, AI can differentiate between various types of arrhythmias with remarkable accuracy, guiding clinicians toward more accurate diagnoses and effective treatment plans. As more data enters AI models, they become increasingly proficient at recognizing subtle indicators, further refining the accuracy of predictions and recommendations. 

For cardiologists, AI serves as a powerful ally, reducing workload and enabling more personalized care. Automation of routine tasks through AI can cut down cardiologists’ administrative workload by 30%, allowing more time for direct patient interaction. For patients, integrating AI into cardiac monitoring translates to better outcomes and a higher standard of care. Patients monitored by AI-based systems reported a 40% increase in satisfaction with their care.

As AI continues to evolve, its role in transforming cardiac care will only become more pronounced, ushering in a new era of precision medicine and proactive health management.

Transformational Today, Foundational Tomorrow 

While transformative today, the three ABCs of acuity in data, better patient experience, and computational power are becoming foundational to the future of cardiac care. One day, we will look back at them much like we do the ECG—as breakthroughs so transformational we can no longer envision cardiac care without them. 

As we navigate challenges like the cardiologist shortage and widespread heart disease, these technological advancements offer a beacon of hope, promising a future in which cardiac health is more detectable, manageable, and accessible than ever before.

InfoBionic.Ai is accelerating remote cardiac monitoring’s AI-enabled future with its MoMe ARC®. Learn more at www.infobionic.ai.

Stuart Long
CEO at InfoBionic.Ai | + posts

Stuart has been the CEO of InfoBionic.Ai since March 2017. He underscores the company’s commitment to widespread market adoption of its transformative wireless remote patient monitoring platform for chronic disease management. With more than 25 years of experience in the medical device market, Stuart brings expertise in achieving rapid commercial growth. Before joining InfoBionic.Ai, he was CEO at Monarch Medical Systems, LLC, and global chief marketing and sales officer for CapsuleTech, Inc. Stuart also held executive positions at healthcare IT-focused companies, including Philips Healthcare, Agfa Healthcare, AMICAS, FUJIFILM USA, and Eastman Kodak.